Licensing deal

Novosound moves into digital health market

Dave Hughes and Dan Irving

Remote sensor specialist Novosound has entered the global digital health and medical imaging market with a major commercial contract. 

The seven-figure R&D and subsequent licensing deal is with a venture capital-backed Israeli company dSound and will see the Newhouse-based company deliver 3D ultrasound technology to the dental imaging market.

CEO and co-founder Dave Hughes said: “Dentistry is currently undergoing digitisation with the emergence of new advanced imaging techniques, and we see scope for our high-resolution ultrasonic technology to make a big impression, first in dental but then across other segments of the global 3D medical imaging market.” 

Mr Hughes added: “As well as my background in dental ultrasound imaging from my PhD, getting into the healthcare market comes round full circle for us.

“One of my academic projects that inspired the founding of Novosound was a collaboration with Current Health’s Chris McCann.

“This was back in 2016 at the University of the West of Scotland, when we secured early-stage R&D grant funding to develop an ultrasound sensor for a medical device to monitor patient hydration levels.”

Founded in 2018, and based at BioCity, Novosound was the first spin-out from the University of the West of Scotland, and recently secured contract wins with aerospace giants BAE Systems and GE Aviation. 

Last year, the company appointed Dr Derek Mathieson, former Chief Marketing and Technology Officer at Baker Hughes, as chairman.  In 2020, it added former BGF investment director Duncan Macrae as chief financial officer.  

Leave a Reply

Your email address will not be published. Required fields are marked as *

This site uses Akismet to reduce spam. Learn how your comment data is processed.